New Delhi: Covaxin from India has been authorised for travel purposes into the UK, allowing tourists and international students, who have been properly inoculated, to enter.
Earlier in November, India's Covaxin was authorised by the World Health Organization (WHO) under Emergency Use Listing (EUL). The UK will now accept all seven Covid vaccines that have obtained emergency approval from the World Health Organization, including India's Covaxin.
With this, Indian students who are fully vaccinated against the covid-19 virus will be able to pursue their studies in person in the UK.
READ | Scientific Evidence Does Not Underline Need For COVID Vaccine Booster Dose: ICMR Expert
According to a notice issued by the Department for Transport and Department of Health and Social Care on Monday, "vaccinations from China's Sinovac Biotech Ltd., state-owned Sinopharm, and India's Bharat Biotech International Ltd. have been added to the list that the United Kingdom uses to grant entry with proof of full vaccination."
Covid Cases Today: India Records 10,488 New Covid-19 Cases, Active Caseload Lowest Since March 2020
"You must be able to prove that you’ve been fully vaccinated under a vaccination programme with approved proof of certification," the department states in order to travel to the UK.
The UK is following in the footsteps of Australia, which increased the number of vaccinations it recognises last month, and the United States, which stated it would accept all WHO-approved vaccines when it opened its borders to international passengers earlier this month.